Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 15, 2023
[ Fri, Sep 15th 2023
] - WOPRAI
[ Fri, Sep 15th 2023
] - WOPRAI
[ Fri, Sep 15th 2023
] - WOPRAI
[ Fri, Sep 15th 2023
] - WOPRAI
[ Fri, Sep 15th 2023
] - WOPRAI
Thu, September 14, 2023
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
[ Thu, Sep 14th 2023
] - WOPRAI
Alex Thompson Maintained (ACRS) at Strong Buy with Increased Target to $20 on, Sep 14th, 2023
Alex Thompson of Stifel, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy with Increased Target from $16 to $20 on, Sep 14th, 2023.
Alex has made no other calls on ACRS in the last 4 months.
There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Alex's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alex
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Tuesday, August 8th, 2023
